Matches in SemOpenAlex for { <https://semopenalex.org/work/W2885545707> ?p ?o ?g. }
- W2885545707 endingPage "e181152" @default.
- W2885545707 startingPage "e181152" @default.
- W2885545707 abstract "<h3>Importance</h3> There exist limited data on the long-term concurrent use of stimulants and opioids among adults with attention-deficit/hyperactivity disorder (ADHD), a population at risk for prescription drug abuse. <h3>Objective</h3> To assess the prevalence and secular trends of and the factors associated with long-term concurrent use of stimulants and opioids among adults with ADHD. <h3>Design, Setting, and Participants</h3> This cross-sectional study assessed Medicaid Analytic eXtract data from 29 states between 1999 and 2010. Medicaid fee-for-service enrollees aged 20 to 64 years with ADHD who were continuously enrolled for more than 12 months after receiving an ADHD diagnosis were included. One 12-month continuous enrollment period was randomly selected as an observation unit for each enrollee. Multivariable regression models were used to determine secular trends in the prevalence of and the potential risk factors associated with long-term concurrent stimulant-opioid use. Analyses were conducted between January 1 and December 31, 2017. <h3>Exposures</h3> Risk factors measured during the first half of the 12-month observation unit. <h3>Main Outcomes and Measures</h3> Prevalence of long-term use of stimulants and opioids overlapping for at least 30 consecutive days was measured during the second half of the randomly selected 12-month observation unit. <h3>Results</h3> Of the 66 406 Medicaid-enrolled adults with ADHD who were identified as eligible, 35 670 (53.7%) were 20 to 30 years old, 37 155 (56.0%) were women, and 52 551 (79.1%) were non-Hispanic white individuals. Of these 66 406 adults with ADHD, 21 723 (32.7%) used stimulants, and 3590 (5.4%) were long-term users of stimulants and opioids. Long-term opioid use was more common among adults with ADHD who used stimulants (3590 of 21 723 [16.5%]) than among those with ADHD who did not use stimulants (5826 of 44 683 [13.0%]). Long-term concurrent stimulant-opioid use increased between 1999 and 2010 (adjusted prevalence relative ratio [PRR], 1.12; 95% CI, 1.10-1.14). Compared with patients aged 20 to 30 years, the prevalence of long-term concurrent stimulant-opioid use was higher among patients in their 30s (PRR, 1.07; 95% CI, 1.07-1.08) and was further increased among patients in their 40s (PRR, 1.14; 95% CI, 1.12-1.15) and 50s (PRR, 1.17; 95% CI, 1.16-1.19). Other strongly associated risk factors included being non-Hispanic white (black PRR, 0.93; 95% CI, 0.92-0.93; other PRR, 0.97; 95% CI, 0.97-0.98; vs white), living in the southern United States (Midwest PRR, 0.98; 95% CI, 0.97-0.98; Northeast PRR, 0.94; 95% CI, 0.93-0.94; West PRR, 0.95; 95% CI, 0.94-0.96; vs South), and receiving a diagnosis of substance abuse disorder (PRR, 1.04; 95% CI, 1.03-1.05), depression (PRR, 1.02; 95% CI, 1.01-1.03), anxiety disorder (PRR, 1.05; 95% CI, 1.04-1.07), chronic pain (PRR, 1.10; 95% CI, 1.07-1.13), chronic obstructive pulmonary disease (PRR, 1.05; 95% CI, 1.04-1.07), or cardiovascular disease (PRR, 1.02; 95% CI, 1.01-1.03). <h3>Conclusions and Relevance</h3> Long-term concurrent use of stimulants and opioids among adults with ADHD is common. This study suggests that clinical and research priorities should be made toward understanding the benefits and risks of long-term coadministration of stimulants and opioids in the management of ADHD and co-occurring pain conditions." @default.
- W2885545707 created "2018-08-22" @default.
- W2885545707 creator A5045780162 @default.
- W2885545707 creator A5059368441 @default.
- W2885545707 creator A5064006627 @default.
- W2885545707 creator A5071037763 @default.
- W2885545707 creator A5086338278 @default.
- W2885545707 date "2018-08-10" @default.
- W2885545707 modified "2023-10-14" @default.
- W2885545707 title "Prevalence of and Factors Associated With Long-term Concurrent Use of Stimulants and Opioids Among Adults With Attention-Deficit/Hyperactivity Disorder" @default.
- W2885545707 cites W1608722015 @default.
- W2885545707 cites W1843981125 @default.
- W2885545707 cites W1963788736 @default.
- W2885545707 cites W1977262135 @default.
- W2885545707 cites W1984738731 @default.
- W2885545707 cites W2017303506 @default.
- W2885545707 cites W2022615536 @default.
- W2885545707 cites W2024012275 @default.
- W2885545707 cites W2033200028 @default.
- W2885545707 cites W2033277137 @default.
- W2885545707 cites W2033304004 @default.
- W2885545707 cites W2037112455 @default.
- W2885545707 cites W2041100912 @default.
- W2885545707 cites W2042460577 @default.
- W2885545707 cites W2051720694 @default.
- W2885545707 cites W2054512694 @default.
- W2885545707 cites W2057887945 @default.
- W2885545707 cites W2058924856 @default.
- W2885545707 cites W2073345301 @default.
- W2885545707 cites W2074807110 @default.
- W2885545707 cites W2079335027 @default.
- W2885545707 cites W2086464859 @default.
- W2885545707 cites W2120831849 @default.
- W2885545707 cites W2129543674 @default.
- W2885545707 cites W2140513029 @default.
- W2885545707 cites W2159202228 @default.
- W2885545707 cites W2159881136 @default.
- W2885545707 cites W2171956687 @default.
- W2885545707 cites W2251367339 @default.
- W2885545707 cites W2257876134 @default.
- W2885545707 cites W2296986887 @default.
- W2885545707 cites W2340078511 @default.
- W2885545707 cites W2414862869 @default.
- W2885545707 cites W2478683222 @default.
- W2885545707 cites W2481048858 @default.
- W2885545707 cites W2517861911 @default.
- W2885545707 cites W2521976164 @default.
- W2885545707 cites W2528505309 @default.
- W2885545707 cites W2563575313 @default.
- W2885545707 cites W2588410069 @default.
- W2885545707 cites W2603705656 @default.
- W2885545707 cites W2738306153 @default.
- W2885545707 cites W36901703 @default.
- W2885545707 cites W4236486344 @default.
- W2885545707 cites W67021727 @default.
- W2885545707 doi "https://doi.org/10.1001/jamanetworkopen.2018.1152" @default.
- W2885545707 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6324259" @default.
- W2885545707 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30646105" @default.
- W2885545707 hasPublicationYear "2018" @default.
- W2885545707 type Work @default.
- W2885545707 sameAs 2885545707 @default.
- W2885545707 citedByCount "21" @default.
- W2885545707 countsByYear W28855457072019 @default.
- W2885545707 countsByYear W28855457072020 @default.
- W2885545707 countsByYear W28855457072021 @default.
- W2885545707 countsByYear W28855457072022 @default.
- W2885545707 countsByYear W28855457072023 @default.
- W2885545707 crossrefType "journal-article" @default.
- W2885545707 hasAuthorship W2885545707A5045780162 @default.
- W2885545707 hasAuthorship W2885545707A5059368441 @default.
- W2885545707 hasAuthorship W2885545707A5064006627 @default.
- W2885545707 hasAuthorship W2885545707A5071037763 @default.
- W2885545707 hasAuthorship W2885545707A5086338278 @default.
- W2885545707 hasBestOaLocation W28855457071 @default.
- W2885545707 hasConcept C118552586 @default.
- W2885545707 hasConcept C126322002 @default.
- W2885545707 hasConcept C160735492 @default.
- W2885545707 hasConcept C162324750 @default.
- W2885545707 hasConcept C170493617 @default.
- W2885545707 hasConcept C187212893 @default.
- W2885545707 hasConcept C2426938 @default.
- W2885545707 hasConcept C2776534028 @default.
- W2885545707 hasConcept C2779418921 @default.
- W2885545707 hasConcept C2780783007 @default.
- W2885545707 hasConcept C2781063702 @default.
- W2885545707 hasConcept C2908647359 @default.
- W2885545707 hasConcept C50522688 @default.
- W2885545707 hasConcept C71924100 @default.
- W2885545707 hasConcept C98274493 @default.
- W2885545707 hasConcept C99454951 @default.
- W2885545707 hasConceptScore W2885545707C118552586 @default.
- W2885545707 hasConceptScore W2885545707C126322002 @default.
- W2885545707 hasConceptScore W2885545707C160735492 @default.
- W2885545707 hasConceptScore W2885545707C162324750 @default.
- W2885545707 hasConceptScore W2885545707C170493617 @default.
- W2885545707 hasConceptScore W2885545707C187212893 @default.
- W2885545707 hasConceptScore W2885545707C2426938 @default.
- W2885545707 hasConceptScore W2885545707C2776534028 @default.